According to CoinMeta, reported by Cailian News on October 28th, Anthropic announced that its life sciences team has established in-depth research collaborations with six new drug development institutions, including Bristol-Myers Squibb and Generate Biomedicines, and has launched an independent drug discovery project. The first focus of this project is on rare childhood muscular dystrophies, with Claude undertaking most of the scientific and operational work.